Investigation into Mersana (NASDAQ: MRSN) by The Ademi Firm concerning potential breaches of fiduciary duty and other legal violations in its recent transaction with Day One Biopharmaceuticals is ongoing. Learn how to participate in the investigation by clicking the provided link. Stay updated on this developing situation.